Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the ...

Board-certified dermatologist with New York City-based MDCS Dermatology Dr. Brendan ... that salicylic acid is a beta hydroxy ...

Finding offers potential new target for treatmentPsoriasis, a painful and uncomfortable inflammatory skin condition that ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...

Opens in a new tab or window Should you see any of these where you apply your psoriasis medication, contact your dermatologist. Is treatment that you apply to the skin right for you? For this type ...

CLEVELAND—Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the activity of disease ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

A new study published in the Archives of Dermatological Research found that patients with psoriasis who were receiving ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...